Patent: 10,584,365
✉ Email this page to a colleague
Summary for Patent: 10,584,365
Title: | Cell culture process |
Abstract: | Polypeptides having target levels of C-terminal variants are described. |
Inventor(s): | Prentice; Holly (Carlisle, MA) |
Assignee: | MOMENTA PHARMACEUTICALS, INC. (Cambridge, MA) |
Application Number: | 15/882,857 |
Patent Claims: | see list of patent claims |
Details for Patent 10,584,365
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 12/31/2002 | ⤷ Try a Trial | 2031-07-08 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 02/21/2008 | ⤷ Try a Trial | 2031-07-08 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 04/24/2013 | ⤷ Try a Trial | 2031-07-08 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 09/23/2014 | ⤷ Try a Trial | 2031-07-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |